Results 91 to 100 of about 52,376 (272)

The prognosis of MG patients with different thymic pathology: a multicenter retrospective cohort study

open access: yesBMC Medicine
Background To identify the associations between thymic pathology and the prognosis of myasthenia gravis (MG) patients. Methods In this multicenter retrospective study, 1,254 myasthenia gravis (MG) patients who underwent thymectomy across four clinical ...
Moli Fan   +11 more
doaj   +1 more source

IgG Subclass (IgG1‐4) and IgA Autoantibody Profiles Against Muscle‐Specific Kinase in a Greek Cohort

open access: yesMuscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims Muscle‐specific kinase myasthenia gravis (MuSK‐MG) is an autoimmune neuromuscular disorder predominantly mediated by IgG4 autoantibodies disrupting MuSK signaling. The contribution of other isotypes remains incompletely defined. We characterized the serological profile of a Greek cohort of MuSK‐MG patients.
Sofia‐Natsοuko Gkotzamani   +22 more
wiley   +1 more source

Thyroid associated orbitopathy with ocular myasthenia in primary hypothyroidism: Keep those eyes open

open access: yesIndian Journal of Endocrinology and Metabolism, 2013
Thyroid associated orbitopathy, although seen most commonly with thyrotoxicosis, is also known to occur in primary hypothyroidism. Myasthenia gravis is an autoimmune condition with an established association with autoimmune thyroid disease. We report the
Chitra Selvan   +11 more
doaj   +1 more source

Bedside and laboratory diagnostic testing in myasthenia

open access: yes, 2022
Myasthenia gravis (MG) and congenital myasthenic syndromes (CMS) are a group of disorders with a well characterised autoimmune or genetic and neurophysiological basis.
Radunovic, Aleksandar   +5 more
core   +1 more source

Optimization of the Cell‐Based Assay Methodology to Study Degradation of Acetylcholine Receptors (Antigenic Modulation) by Antibodies From Myasthenia Gravis Patients

open access: yesMuscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims Degradation of cell‐surface acetylcholine receptors (AChRs) by antigenic modulation is a key pathogenic mechanism of myasthenia gravis (MG) autoantibodies, yet standard assays primarily detect antibody binding rather than functional effects.
Peng Du   +7 more
wiley   +1 more source

Pharmacotherapy of Myasthenia Gravis

open access: yes, 2015
The pharmacotherapy of Myasthenia Gravis is gradually advancing with special regard to immunospuression.
Omar, Majeed
core  

Urinary Dysfunction in Myasthenic Syndromes: A Scoping Review of Clinical Features and Treatment‐Related Associations

open access: yesMuscle &Nerve, EarlyView.
ABSTRACT Urinary dysfunction has been reported in association with myasthenic syndromes, including myasthenia gravis (MG), Lambert–Eaton myasthenic syndrome (LEMS), and congenital myasthenic syndromes (CMS), but evidence regarding its prevalence, clinical impact, pathophysiology, and management remains limited.
Julia M. Augustin   +13 more
wiley   +1 more source

Patient Communication Outside of Visits: Implications for Remote Monitoring and Digital Care Models in Myasthenia Gravis

open access: yesMuscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims Myasthenia gravis (MG) is a rare autoimmune disorder requiring individualized, specialized treatment, yet access to specialized care is limited and documentation fragmented. Several remote monitoring tools have emerged to address this gap, yet their integration into clinical care remains challenging.
Maike Stein   +7 more
wiley   +1 more source

Frontalis sling procedure for ocular myasthenia gravis

open access: yes, 2012
Shinichi Asamura1, Hirohiko Kakizaki2, Mitsuhiro Enjyo1, Takahiro Hashimoto1, Noritaka Isogai11Department of Plastic and Reconstructive Surgery, Kinki University School of Medicine, Osakasayama, Osaka, Japan; 2Department of Ophthalmology, Aichi Medical ...
Hashimoto T   +4 more
core  

Clinical Presentations of Myasthenia Gravis [PDF]

open access: yes, 2018
This chapter describes signs and symptoms characteristic for postsynaptic neuromuscular junction diseases, how to validate them, and when to attribute them to myasthenia or another neurological disease.
Kuks, Jan B.M., Jan B. M. Kuks
core   +1 more source

Home - About - Disclaimer - Privacy